April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Uveitic Glaucoma: Long-Term Outcomes of Mitomycin-C Trabeculectomy
Author Affiliations & Notes
  • R. A. Puertas
    Glaucoma,
    Moorfields Eye Hospital, London, United Kingdom
  • K. Kaltsos
    Glaucoma,
    Moorfields Eye Hospital, London, United Kingdom
  • K. S. Lim
    Glaucoma, St. Thomas' Hospital, London, United Kingdom
  • S. L. Lightman
    Medical Retina,
    Moorfields Eye Hospital, London, United Kingdom
  • C. E. Pavesio
    Medical Retina,
    Moorfields Eye Hospital, London, United Kingdom
  • C. Bunce
    Glaucoma,
    Moorfields Eye Hospital, London, United Kingdom
  • K. Barton
    Glaucoma,
    Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  R.A. Puertas, None; K. Kaltsos, None; K.S. Lim, None; S.L. Lightman, None; C.E. Pavesio, None; C. Bunce, None; K. Barton, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 166. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. A. Puertas, K. Kaltsos, K. S. Lim, S. L. Lightman, C. E. Pavesio, C. Bunce, K. Barton; Uveitic Glaucoma: Long-Term Outcomes of Mitomycin-C Trabeculectomy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):166.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the long-term success of Mitomycin Ctrabeculectomy in uveitic glaucoma and to identify predictors of failure.

Results: : 153 eyes were followed 52 months (median)(range 12 - 115). The preoperative IOP of 29.9 ± 7.6 mmHg (mean ± SD) on 3.3 ± 0.8 medications dropped to 13.9 ± 6.7mmHg on 0.7 ± 1.1 medications at last follow-up. The median preop VA of 6/9 (range 6/5 - HM) was unchanged at last follow-up (6/9, range 6/5 to LP). 118 (77.1%) were using topical steroids, 30 (19.6%) systemic steroids and 13 (8.5%) systemic immunosuppression before surgery. Failure: There were 86 (54.9%) complete successes, 39 qualified failures (25.4%), 15 (9.8%) failures and 15 (9.8%) complete failures. We found little evidence of association between age, gender, race, type of uveitis and the failure categories. Preoperative IOP (p = 0.042) was associated with higher risk. There was a slight excess risk (of borderline significance, p = 0.068) in the 44 pseudophakic eyes (28.8%). However, in comparison with the 42 (27.5%) eyes that remained phakic throughout, pseudophakes (p=0.009) and those having later cataract surgery (67, 43.8%)(p = 0.039) were more likely to fail.

Conclusions: : 72.5% of trabeculectomy eyes required cataract surgery, with a detrimental influence on IOP control. The optimal timing for cataract surgery warrants further investigation.

Keywords: uveitis-clinical/animal model • intraocular pressure • clinical (human) or epidemiologic studies: systems/equipment/techniques 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×